The Evolut R and Evolut PRO transcatheter aortic valve systems

References

• Forrest JK, Mangi AA, Popma JJ, et al. Early outcomes with the Evolut PRO repositionable self-expanding transcatheter aortic valve with pericardial wrap. JACC Cardiovasc Interv. 2018;11:160–168.
   PubMed Web of Science ®Google Scholar
• Piazza N, Martucci G, Lachapelle K, et al. First-in-human experience with the Medtronic CoreValve Evolut R. EuroIntervention. 2014;9:1260–1263.
   PubMed Web of Science ®Google Scholar
• Bagur R, Kwok CS, Nombela-Franco L, et al. Transcatheter aortic valve implantation with or without preimplantation balloon aortic valvuloplasty: a systematic review and meta-analysis. J Am Heart Assoc. 2016;5. DOI:10.1161/JAHA.115.003191
   Web of Science ®Google Scholar
• Martin GP, Sperrin M, Bagur R, et al. Pre-implantation balloon aortic valvuloplasty and clinical outcomes following transcatheter aortic valve implantation: a propensity score analysis of the UK registry. J Am Heart Assoc. 2017;6. DOI:10.1161/JAHA.116.004695
   Web of Science ®Google Scholar
• Bagur R, Teefy PJ, Kiaii B, et al. First North American experience with the transfemoral ACURATE-neoTM self-expanding transcatheter aortic bioprosthesis. Catheter Cardiovasc Interv. 2017;90:130–138.
   PubMed Web of Science ®Google Scholar
• Chu MW, Bagur R, Losenno KL, et al. Early clinical outcomes of a novel self-expanding transapical transcatheter aortic valve bioprosthesis. J Thorac Cardiovasc Surg. 2017;153:810–818.
   PubMed Web of Science ®Google Scholar
• Harrison JK, Hughes GC, Reardon MJ, et al. Balloon post-dilation following implantation of a self-expanding transcatheter aortic valve bioprosthesis. JACC Cardiovasc Interv. 2017;10:168–175.
   PubMedGoogle Scholar
• Manoharan G, Walton AS, Brecker SJ, et al. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv. 2015;8:1359–1367.
   PubMed Web of Science ®Google Scholar
• Popma JJ, Reardon MJ, Khabbaz K, et al. Early clinical outcomes after transcatheter aortic valve replacement using a novel self-expanding bioprosthesis in patients with severe aortic stenosis who are suboptimal for surgery: results of the Evolut R U.S. study. JACC Cardiovasc Interv. 2017;10:268–275.
   PubMed Web of Science ®Google Scholar
• Grube E, Van Mieghem NM, Bleiziffer S, et al. Clinical outcomes with a repositionable self-expanding transcatheter aortic valve prosthesis: the international FORWARD study. J Am Coll Cardiol. 2017;70:845–853.
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 2012;42:S45–S60.
   PubMed Web of Science ®Google Scholar
• Noble S, Stortecky S, Heg D, et al. Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. EuroIntervention. 2017;12:e2170–e2176.
   PubMed Web of Science ®Google Scholar
• Giannini C, De Carlo M, Tamburino C, et al. Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: a case-matched comparison. Int J Cardiol. 2017;243:126–131.
   PubMed Web of Science ®Google Scholar
• van Rosendael PJ, Delgado V, Bax JJ. Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review. Eur Heart J. 2018;39:2003–2013.
   PubMed Web of Science ®Google Scholar
• Perrin N, Perrin T, Hachulla AL, et al. Conduction disorders using the Evolut R prosthesis compared with the CoreVSalve: has anything changed? Open Heart. 2018;5:e000770.
   PubMed Web of Science ®Google Scholar
• Kalra SS, Firoozi S, Yeh J, et al. Initial experience of a second-generation self-expanding transcatheter aortic valve: the UK & Ireland Evolut R implanters’ registry. JACC Cardiovasc Interv. 2017;10:276–282.
   PubMed Web of Science ®Google Scholar
• Perrin N, Roffi M, Frei A, et al. Thirty-day outcome following CoreValve Evolut R transcatheter aortic valve implantation: an all-comers prospective study. Rev Esp Cardiol. 2017;70:713–719.
   PubMed Web of Science ®Google Scholar
• Harnath A, Gomes B, Herwig V, et al. First experience with the 34 mm self-expanding Evolut R in a multicentre registry. EuroIntervention. 2018;14:e298–e300.
   PubMed Web of Science ®Google Scholar
• Kuhn C, Frerker C, Meyer AK, et al. Transcatheter aortic valve implantation with the 34 mm self-expanding CoreValve Evolut R: initial experience in 101 patients from a multicentre registry. EuroIntervention. 2018;14:e301–e305.
   PubMed Web of Science ®Google Scholar
• Sorajja P, Kodali S, Reardon MJ, et al. Outcomes for the commercial use of self-expanding prostheses in transcatheter aortic valve replacement: a report from the STS/ACC TVT registry. JACC Cardiovasc Interv. 2017;10:2090–2098.
   PubMed Web of Science ®Google Scholar
• Schulz E, Jabs A, Gori T, et al. Transcatheter aortic valve implantation with the new-generation Evolut R: comparison with CoreValve(R) in a single center cohort. Int J Cardiol Heart Vasc. 2016;12:52–56.
   PubMed Web of Science ®Google Scholar
• Gomes B, Geis NA, Chorianopoulos E, et al. Improvements of procedural results with a new-generation self-expanding transfemoral aortic valve prosthesis in comparison to the old-generation device. J Interv Cardiol. 2017;30:72–78.
   PubMed Web of Science ®Google Scholar
• Ben-Shoshan J, Konigstein M, Zahler D, et al. Comparison of the Edwards SAPIEN S3 versus Medtronic Evolut-R devices for transcatheter aortic valve implantation. Am J Cardiol. 2017;119:302–307.
   PubMed Web of Science ®Google Scholar
• Enriquez-Rodriguez E, Amat-Santos IJ, Jimenez-Quevedo P, et al. Comparison of the hemodynamic performance of the balloon-expandable SAPIEN 3 versus self-expandable Evolut R transcatheter valve: a case-matched study. Rev Esp Cardiol. 2018;71:735–742.
   PubMed Web of Science ®Google Scholar
• Eitan A, Witt J, Stripling J, et al. Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in transcatheter aortic valve replacement patients with larger annuli: early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with annuli >/=26 mm. Catheter Cardiovasc Interv. 2018 March 9. Epub ahead of print. DOI:10.1002/ccd.27588
   PubMed Web of Science ®Google Scholar
• Thiele H. SOLVE-TAVI. A 2 × 2 randomized trial of self-expandable vs balloon-expandable valves and general vs local anesthesia in patients undergoing transcatheter aortic valve implantation. Presented at: Transcatheter and Cardiovascular Therapeutics; 2018; San Diego, USA.
   Google Scholar
• Williams MR 1-year outcomes with the Evolut PRO self-expanding repositionable transcatheter aortic valve with pericardial wrap. Presented at the American College of Cardiology 67th Annual Scientific Session Orlando; 2018 March; Florida, USA.
   Google Scholar
• Bagur R, Pibarot P, Otto CM. Importance of the valve durability-life expectancy ratio in selection of a prosthetic aortic valve. Heart. 2017;103:1756–1759.
   PubMed Web of Science ®Google Scholar
• Foroutan F, Guyatt GH, Otto CM, et al. Structural valve deterioration after transcatheter aortic valve implantation. Heart. 2017;103:1899–1905.
   PubMed Web of Science ®Google Scholar
• Brecker S Longest follow-up after implantation of a self-expanding repositionable transcatheter aortic valve: final follow-up of the Evolut R CE study. Presented at: Transcatheter and Cardiovascular Therapeutics; 2016; Washington, DC, USA.
   Google Scholar